Jan 12

This week, included are two reports of safety issues (Depo Provera and Ozempic) that did not involve an FDA update but are noteworthy due to lawsuits and European Medicines Agency (EMA) interest.

Comments

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Ask a Patient® Health News: Drugs & Treatments

January 2025 Part 1: Safety warning for RSV…